BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//MediWales - ECPv6.6.4.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://mediwales.com
X-WR-CALDESC:Events for MediWales
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20181028T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181211
DTEND;VALUE=DATE:20181213
DTSTAMP:20260406T184456
CREATED:20180907T134226Z
LAST-MODIFIED:20180907T134226Z
UID:14687-1544486400-1544659199@mediwales.com
SUMMARY:The New England Venture Summit
DESCRIPTION:The 12th annual New England Venture Summit\, presented by youngStartup Ventures\, is the premier industry gathering connecting venture capitalists\, corporate VCs\, angel investors\, technology transfer professionals\, senior executives of early stage and emerging growth companies\, university researchers\, incubators and premier service providers. \nWhether you are an investor seeking access to new early stage deals\, or a CEO or Founder of a new venture looking for funding\, visibility and growth\, New England Venture Summit is one event you won’t want to miss. \n10% discount registration for members. \nFind out more here
URL:https://mediwales.com/event/the-new-england-venture-summit/
LOCATION:Unnamed Venue\, Boston
CATEGORIES:External
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181211
DTEND;VALUE=DATE:20181214
DTSTAMP:20260406T184456
CREATED:20180907T134334Z
LAST-MODIFIED:20180907T134334Z
UID:14689-1544486400-1544745599@mediwales.com
SUMMARY:BioBusiness Winter Retreat
DESCRIPTION:Whether you are still in academia (as PhD student or postdoc) or already working in industry\, this course will help you to reflect on the developments in the fast-changing life sciences industry and your place in it. The program will go into the trends and developments in the life science sector\, give examples of emerging business models and discuss funding and partnering strategies for life sciences companies. This knowledge will allow you to steer your career in such a way that it benefits the most from the changing landscape. \n15% discount on registration for members. \nFind out more here
URL:https://mediwales.com/event/biobusiness-winter-retreat/
LOCATION:Unnamed Venue\, Ghent
CATEGORIES:External
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20181212T103000
DTEND;TZID=Europe/London:20181212T160000
DTSTAMP:20260406T184456
CREATED:20181023T082444Z
LAST-MODIFIED:20181023T082444Z
UID:14793-1544610600-1544630400@mediwales.com
SUMMARY:EU Medical Device & IVD Regulations Workshop
DESCRIPTION:SEHTA\, Psephos Biomedica & Mosaic Surgical would like to invite you to attend our EU Medical Device & IVD Regulations – Strategy & Requirements Workshop. \nDate: Wednesday 12 December 2018 \nVenue: Hempsons\, 100 Wood Street\, London EC2V 7AN \nTimes: 10:30 – 16:00 \nCost: SEHTA Members £199 + VAT / Non-Members £225 + VAT per delegate.  You will be invoiced by SEHTA via PayPal after you have registered. \n(it’s free to join SEHTA – just click here) \n  \nWhy attend \nThe new EU Medical Device Regulation (MDR) is in its implementation phase and will be effective from May 2020.  All medical devices will need to comply with this new legislation.  Similarly\, the IVD Regulation (IVDR) will be in force from May 2022.  Many companies are not yet ready for the journey let alone have a roadmap of how to get to compliance. \n  \nThis one-day event will:- \nProvide you with an overview of the key areas likely to need upgrading to comply with the MDR/IVDR\nAssist you in assessing your company’s current preparedness for the transition\nGive you a clear\, practical guide to the next steps that you and your company need to take to gain CE Marking under the MDR/IVDR \n  \nOutcomes  \nGain an overview of the new EU Medical Device and IVD Regulations\nUnderstand the key areas of compliance required\nUnderstand the technical documentation that should be in place for each device\nGain a plan of action for implementation and CE Marking under the new legislation \n  \n  \nREGISTER YOUR INTEREST HERE! \nThe organisers reserve the right to decline registrations based on review. All applicants will be notified by email if they have been accepted for a place no later than Monday 10th December. \n  \nAgenda \n10:30 – 10:45  Registration & Refreshments \n10:45 – 10:55  Welcome\, Jacques Du Preez\, MD\, Mosaic Surgical & Neil Roberts\, COO\, SEHTA \n10:55 – 11:35  MDR/IVDR Overview & Q&A\, Robin Stephens\, CEO\, Psephos Biomedica \n11:35 – 12:15  Technical Documentation & Q&A\, Jacques Du Preez\, MD\, Mosaic Surgical \n12:15 – 13:00  Networking Lunch Break \n13:00 – 13:40  Post-Market Activities (Inc PSUR) Q&A\, Robin Stephens\, CEO\, Psephos Biomedica \n13:40 – 14:10  EUDAMed and UDI & Q&A\, Jacques Du Preez\, MD\, Mosaic Surgical \n14:10 – 14:40  Clinical Evidence & Q&A\, Robin Stephens\, CEO\, Psephos Biomedica \n14:40 – 15:00  Refreshment Break \n15:00 – 16:00  Roundtable discussion on Implementation Strategies (inc Q&A) \n 
URL:https://mediwales.com/event/eu-medical-device-ivd-regulations-workshop/
LOCATION:Hempsons\, 100 Wood Street\,  London\, EC2V 7AN\, United Kingdom
CATEGORIES:External
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20181212T103000
DTEND;TZID=Europe/London:20181212T160000
DTSTAMP:20260406T184456
CREATED:20181031T121130Z
LAST-MODIFIED:20181031T121130Z
UID:14816-1544610600-1544630400@mediwales.com
SUMMARY:The New EU Medical Device & IVD Regulations: Strategy & Requirements Workshop
DESCRIPTION:SEHTA\, Psephos Biomedica & Mosaic Surgical would like to invite you to attend our EU Medical Device & IVD Regulations – Strategy & Requirements Workshop on Wednesday 12th December in London. \nWhy attend\nThe new EU Medical Device Regulation (MDR) is in its implementation phase and will be effective from May 2020.  All medical devices will need to comply with this new legislation.  Similarly\, the IVD Regulation (IVDR) will be in force from May 2022.  Many companies are not yet ready for the journey let alone have a roadmap of how to get to compliance. \nThis one-day event will:- \n\nProvide you with an overview of the key areas likely to need upgrading to comply with the MDR/IVDR\nAssist you in assessing your company’s current preparedness for the transition\nGive you a clear\, practical guide to the next steps that you and your company need to take to gain CE Marking under the MDR/IVDR\n\nOutcomes \n\nGain an overview of the new EU Medical Device and IVD Regulations\nUnderstand the key areas of compliance required\nUnderstand the technical documentation that should be in place for each device\nGain a plan of action for implementation and CE Marking under the new legislation\n\n  \nCosts to attend – You will be invoiced via SEHTA via PayPal \nSEHTA Members – £199 + VAT per delegate \nSEHTA non-members – £225 + VAT per delegate (it’s free to join SEHTA – Please click here) \nThe organisers reserve the right to decline registrations based on review. All applicants will be notified by email if they have been accepted for a place no later than Monday 10th December. \n  \nREGISTER YOUR INTEREST  \n  \nAgenda \n10:30 – 10:45  Registration & Refreshments\n10:45 – 10:55  Welcome\, Jacques Du Preez\, MD\, Mosaic Surgical & Neil Roberts\, COO\, SEHTA\n10:55 – 11:35  MDR/IVDR Overview & Q&A\, Robin Stephens\, CEO\, Psephos Biomedica\n11:35 – 12:15  Technical Documentation & Q&A\, Jacques Du Preez\, MD\, Mosaic Surgical\n12:15 – 13:00  Networking Lunch Break\n13:00 – 13:40  Post-Market Activities (Inc PSUR) Q&A\, Robin Stephens\, CEO\, Psephos Biomedica\n13:40 – 14:10  EUDAMed and UDI & Q&A\, Jacques Du Preez\, MD\, Mosaic Surgical\n14:10 – 14:40  Clinical Evidence & Q&A\, Robin Stephens\, CEO\, Psephos Biomedica\n14:40 – 15:00  Refreshment Break\n15:00 – 16:00  Roundtable discussion on Implementation Strategies (inc Q&A)
URL:https://mediwales.com/event/the-new-eu-medical-device-ivd-regulations-strategy-requirements-workshop/
LOCATION:Hempsons\, 100 Wood Street\, London\, EC2V 7AN\, United Kingdom
CATEGORIES:External
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20181213
DTEND;VALUE=DATE:20181214
DTSTAMP:20260406T184456
CREATED:20171220T105302Z
LAST-MODIFIED:20180710T130627Z
UID:14045-1544659200-1544745599@mediwales.com
SUMMARY:Genesis 2018
DESCRIPTION:Driving success in Life Science & Healthcare: Convergence of Technology\, Investment and People \nBuilding on the evolution of the past 17 years\, Genesis 2018 will assemble senior executives and decision makers from across the Life Science and Healthcare field to present\, discuss and demonstrate their collective insight and thought leadership for the sector\, themselves and their stakeholders. \nAdvances in R&D technologies\, an increasingly inter-disciplinary approach to the diagnosis and treatment of health disorders and a continuing diversification of capital sources is enabling the transformation of great science into great solutions at a global scale. \nWhilst global healthcare challenges are ever changing\, advances in science and technology have never been faster. The new insights and ability such advances afford those discovering\, developing and delivering better solutions for patients leaves the sector well-placed to meet the challenges ahead. Addressing patients’ unmet needs of course brings for researchers\, clinicians\, investors\, payers and policymakers the opportunity to make a real world difference. \nUnder the overarching theme of Driving success in Life Sciences & Healthcare: Convergence of Technology\, Investment and Talent our 18th Annual Genesis Conference\, will take place on Thursday 13 December 2017 in London. The event will again engage all the key elements for those active in R&D\, finance\, policy making and service provision across Life Sciences\, Digital and Health Technology fields in creating a vision of where the sector is heading. Over 70 expert speakers and panellists will lead sessions discussing which approaches will deliver better outcomes for patients\, investors and payers. \n\n\n\n10% discount on registration for ULS members. \n\n\n\nFind out more here
URL:https://mediwales.com/event/genesis-2018/
CATEGORIES:External
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190106
DTEND;VALUE=DATE:20190107
DTSTAMP:20260406T184456
CREATED:20180907T134422Z
LAST-MODIFIED:20180907T134422Z
UID:14691-1546732800-1546819199@mediwales.com
SUMMARY:2nd Annual Neuroscience Innovation Forum
DESCRIPTION:Building on the success of our last year’s forum we are pleased to announce The 2nd Annual Neuroscience Innovation Forum for BD&L and Investment in Therapeutics and Technology to take place at the Marines’ Memorial Club\, San Francisco on the 6th of January 2019\, a day before the JP Morgan meeting. \nThe program will cover BioPartnering for CNS\, with industry keynotes and panels on AD\, PD\, Neuropsychiatry and Pain Management. Moreover there are panels on innovation in NeuroTech covering banking\, device\, diagnostics and software. \n10% discount on registration for members. \nFind out more here
URL:https://mediwales.com/event/2nd-annual-neuroscience-innovation-forum/
LOCATION:Unnamed Venue\, San Francisco
CATEGORIES:External
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190107
DTEND;VALUE=DATE:20190110
DTSTAMP:20260406T184456
CREATED:20180710T130816Z
LAST-MODIFIED:20181112T112203Z
UID:14570-1546819200-1547078399@mediwales.com
SUMMARY:Biotech Showcase 2019
DESCRIPTION:Hear from 400 public and private biotechnology and life sciences companies during JP Morgan week – the most impactful week for the life sciences industry! Biotech Showcase attracts 3\,300 attendees including innovative biotech companies\, public and private investors\, pharmaceutical executives\, professional advisors and potential partners. \nMediWales members through BioPartner receive $350 discount on registration. \nFind out more here \n 
URL:https://mediwales.com/event/biotech-showcase-2019/
CATEGORIES:External,International Events
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190108
DTEND;VALUE=DATE:20190109
DTSTAMP:20260406T184456
CREATED:20180907T134510Z
LAST-MODIFIED:20180907T134510Z
UID:14693-1546905600-1546991999@mediwales.com
SUMMARY:RESI San Francisco 2019
DESCRIPTION:The Redefining Early Stage Investments (RESI) conference series is an established global circuit partnering conference for early stage life science companies to source investors\, create relationships\, and close the gap on finding capital. These events give life science companies the chance to start\, resume or close conversations with relevant investors\, creating a global dialogue to bring products to market at a faster pace. RESI brings qualified investors from ten categories including\, Family Offices\, Venture Philanthropy\, Patient Groups\, Corporate Development\, Virtual Pharma\, Endowments\, Foundation\, and Angels. \nThe conference helps facilitate face to face meetings between companies and investors based on a common fit (indication\, technology & stage of development) which promotes compelling conversations\, facilitating the development of qualified investor to entrepreneur relationships. The RESI Conference also serves as an excellent opportunity for large pharma/ medtech companies and service providers to connect with attending companies and investors representing their portfolio companies. \n$100 discount on registration for members. \nFind out more here
URL:https://mediwales.com/event/resi-san-francisco-2019/
LOCATION:Unnamed Venue\, San Francisco
CATEGORIES:External
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190108T080000
DTEND;TZID=Europe/London:20190108T170000
DTSTAMP:20260406T184456
CREATED:20190108T160302Z
LAST-MODIFIED:20190108T160302Z
UID:15170-1546934400-1546966800@mediwales.com
SUMMARY:Bionow Oncology Conference
DESCRIPTION:Focusing upon the strengths in the discovery\, development and manufacture of cancer medicines in the North of England through to commercialisation (patients)\, this event will highlight industry\, academic and clinical strengths whilst showcasing key activities\, infrastructure and the joined up translational environment which exists in the North. \nConference Programme \n\n\n\nTime\nSession\nSpeakers\n\n\n08.30 – 09.00\nCoffee & Registration\n\n\n\n09.00 – 09.05\nWelcome\nGeoff Davison\, CEO\, Bionow\n\n\n09.05 – 09.25\nKeynote Speaker\n\n\n\n09.25 – 10.40\nEmerging Pre-Clinical Technologies in Oncology \nChair: Peter Simpson\, Chief Scientific Officer\, Medicines Discovery Catapult\nAndrew Campbell\, Cancer Geneticist\, CRUK Beatson Institute\nJon Wingfield\, Principal Scientist\, AstraZeneca\nGayle Marshall\, Lead Scientist – Biomarkers\, Medicines Discovery Catapult\nTiffany Thorn\, CEO\, BiVictriX\n\n\n10.40 – 11.10\nCoffee\, Networking & Exhibition\n\n\n\n11.10 – 12.25\nTranslating Advanced Therapies \nChair: Steve McConchie\, CEO\, Aptus Clinical\nFiona Thistlewaite\, Medical Oncology Consulltant\, The Christie \nDaniel Smith\, Chief Scientific Officer\, Cobra Biologics\nSteve Anderton\, Chair of Therapeutic Immunology\, University of Edinburgh\n\n\n12.25 – 13.35\nLunch\, Networking & Exhibition\n\n\n\n13.35 – 13.55\nKeynote Speaker\n\n\n\n13.55 – 15.10\nAdvanced Drug Delivery Systems / Manufacturing\nMarcel De Matas\, Director of Product Design\, Seda Pharmaceutical\nMaya Thanou\, Senior Lecturer\, Kings College\nN4 Pharma\n\n\n15.10 – 15.30\nCoffee\, Networking & Exhibition\n\n\n\n15.30 – 16.45\nHealth Economics / Regulation\nGrace Jennings\, Senior Scientific Advisor\, NICE\n\n\n16.45 – 17.30\nSummary Panel\n\n\n\n17.30\nClose\n\n\n\nDelegate Fees\nPremium Member: £99.00 + VAT per delegate\nMember: £125.00 + VAT per delegate\nNon-Member: £155.00 + VAT per delegate \nDiscounted rates for group booking are available (5+ delegates). \nIf you are interested in sponsorship or exhibition opportunities at the conference please contact Helen Williams on 07714 168020 or at helen.williams@bionow.co.uk.
URL:https://mediwales.com/event/bionow-oncology-conference/
LOCATION:Alderley Park Conference Centre\, Alderley Park\, Nether Alderley\, Macclesfield\,\, SK10 4TG
CATEGORIES:External
ORGANIZER;CN="Bionow":MAILTO:helen.williams@bionow.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190115T090000
DTEND;TZID=Europe/London:20190115T100000
DTSTAMP:20260406T184456
CREATED:20190103T144341Z
LAST-MODIFIED:20190103T144341Z
UID:15159-1547542800-1547546400@mediwales.com
SUMMARY:WEBINAR: Understanding the Medical Devices Market in Japan
DESCRIPTION:Japan’s medical devices and healthcare market offer business opportunities for innovative British companies. It is the second largest medical devices market after the US with a large number of hospitals. It offers universal access and national healthcare services\, and the world’s highest life expectancies. Premium pricing is also available for healthcare innovations. \nWith a market size of £19.8 billion in 2014\, Japan’s medical devices market heavily relies on imports\, especially for therapeutic devices\, which consist of nearly 50% of the total domestic sales volume. The UK is ranked as the 8th largest exporter of medical devices to Japan. Since the revision of the Pharmaceutical and Medical Devices Act in 2014\, regulations on medical devices have been modified to allow faster and easier access to the Japanese medical devices market. Japan’s approval process is now roughly equivalent to the US. \nJapan offers a great opportunity for UK companies involved in the development of innovative medtech and medical device\, especially for therapeutic devices. The top 5 main therapeutic device categories are: \n1) artificial internal organ apparatus and assist device;\n2) operating equipment and supplies;\n3) ophthalmic goods;\n4) diagnostic imaging system; and\n5) therapeutic and surgical equipment. \nThe Japanese government is leading on the following 5 key focused area: Surgical robot\, artificial organ/ tissues\, minimum invasive surgery\, diagnostic imaging\, home medical treatment equipment. \nAbout the speaker\nMr. Taiki Ishikura\, Director & Chief Business Officer of Japan Organisation for Medical Device Development Inc (JOMDD). \nJOMDD is the first-ever medical device incubator in Japan\, sourcing early-stage technologies from overseas and commercialise them globally. \nJOMDD has strong ties with Japanese universities\, medium-sized companies and governments with a nationwide network having a strategic alliance with the largest MD association\, Japan Medical Association. \nFor more information: https://jomdd.com/en/ \n  \nREGISTER HERE
URL:https://mediwales.com/event/webinar-understanding-the-medical-devices-market-in-japan/
LOCATION:British Embassy Tokyo
CATEGORIES:External,International Events
ORGANIZER;CN="Department for International Trade":MAILTO:info@exporttojapan.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190115T181500
DTEND;TZID=Europe/London:20190115T194500
DTSTAMP:20260406T184456
CREATED:20190103T131915Z
LAST-MODIFIED:20190103T132820Z
UID:15145-1547576100-1547581500@mediwales.com
SUMMARY:Why are we worried about Cyber?
DESCRIPTION:Register here \n\nData is everywhere\, and everything has a price\nData is the lifeblood of business\nData can be sensitive and valuable\nIs your data safe?\n\nWho is attacking you and why? \nCyber Security brought to you by Grant Thornton’s experts promises to be an interesting\, informative and interactive event. \nBreaches – Time is money \nPhishing – Stay secure \nVulnerabilities – Threat monitoring and detection \nAttacks – The cyber security lifecycle \n  \nJust some of the topics being discussed on the night. If you believe your organisation could be at risk then this is a must attend event. \n  \nWhat? \nWhy are we worried about Cyber? \nWhen? \nTuesday 15 January 18:00 – 19:45 \nWhere? \nMilk and Sugar – One Central Square CF10 1FS \nDress code \nYour usual business attire \nRSVP \nLouise Medina \nE: louise.medina@uk.gt.com \nT: 02920 347 563 \n  \nFind out more information about Cyber security linking to the event below: \nCyber Promotion – CIBS Flyer \nCyber Promotion – Cyber Health Check Flyer
URL:https://mediwales.com/event/why-are-we-worried-about-cyber/
LOCATION:Milk and Sugar\, One Central Square\, Cardiff\, CF10 1FS
CATEGORIES:External
ORGANIZER;CN="Grant Thornton":MAILTO:louise.medina@uk.gt.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190116
DTEND;VALUE=DATE:20190117
DTSTAMP:20260406T184456
CREATED:20180907T134554Z
LAST-MODIFIED:20180907T134554Z
UID:14695-1547596800-1547683199@mediwales.com
SUMMARY:BioSeed 2019
DESCRIPTION:BioSeed is a platform for innovative life science companies to present and meet with sector specific early stage investors. The event’s one day format – with presentations in the morning\, a networking lunch and partnering sessions in the afternoon – offers plenty of opportunities for companies and investors to network. \n10% discount on registration for members. \nFind out more here
URL:https://mediwales.com/event/bioseed-2019/
LOCATION:Unnamed Venue\, London
CATEGORIES:External
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190124T190000
DTEND;TZID=Europe/London:20190124T235500
DTSTAMP:20260406T184456
CREATED:20181003T101952Z
LAST-MODIFIED:20181003T101952Z
UID:14741-1548356400-1548374100@mediwales.com
SUMMARY:BIA Gala Dinner 2019
DESCRIPTION:Get ready for the best night in the biosciences calendar. The legendary BIA Gala Dinner is the place to be this January\, network\, connect and enjoy a fabulous evening with fantastic people. \nJoin us for the best night in the bioscience calendar and network with the biggest names in the industry at the BIA Gala Dinner. The flagship BIA Gala Dinner continues to be the premier bioscience networking event of the year and we invite you to join us at the Brewery for another sparkling evening in stunning surroundings. \nThe evening provides an excellent opportunity to entertain valued existing clients\, network with prospective customers and generate new business\, and we invite you to join us once again for a sparkling night at The Brewery for an evening of excellent food\, fine wine and good company. \nThe evening will start at 19.00 with a champagne and canapé networking reception in the King George III suite (named after his visit in 1787) which has exposed brickwork and a barrel-vaulted ceiling. \nA splendid four-course meal will take place in the Porter Tun\, one of the largest and oldest unobstructed event spaces in London. Service will start at 20.40. \nFind out more here
URL:https://mediwales.com/event/bia-gala-dinner-2019/
LOCATION:The Brewery\, 52 Chiswell Street\, London\, EC1Y 4SD\, United Kingdom
CATEGORIES:External
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190126
DTEND;VALUE=DATE:20190202
DTSTAMP:20260406T184456
CREATED:20180614T154019Z
LAST-MODIFIED:20180820T093008Z
UID:14408-1548460800-1549065599@mediwales.com
SUMMARY:Arab Health 2019
DESCRIPTION:The Middle East healthcare business is expected to be worth $60 billion by 2025 as the need for investment in services and facilities increases. It is one of the few regions in the world that faces such a rapid increase in demand and this growth is creating new opportunities in the healthcare sector. The Arab Health Exhibition and Congress is\, by far\, the largest healthcare exhibition in the Middle East\, and one of the largest in the world. The 2017 exhibition showcased more than 4\,000 companies exhibiting their latest innovations across 23 halls with 97\,000 healthcare professionals attending from 159 countries. Arab Health provides a platform for companies to develop business across the region. The Welsh Government can also help your business to arrange meetings during the event either with like minded companies or potential customers via our export trade support programmes. \nThe Welsh Government is subsidising companies to either exhibit at Arab Health or visit as part of an export market visit. Email lifesciences@gov.wales for more info or click here for further details.
URL:https://mediwales.com/event/arab-health-2019/
CATEGORIES:External,International Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190205T100000
DTEND;TZID=Europe/London:20190205T161500
DTSTAMP:20260406T184456
CREATED:20190103T134719Z
LAST-MODIFIED:20190103T134719Z
UID:15152-1549360800-1549383300@mediwales.com
SUMMARY:The New EU Medical Device & IVD Regulations: Implementation Insights Workshop
DESCRIPTION:Medilink members fee – £180 + VAT per delegate* \n\nMedilink non-members fee – £215 + VAT per delegate*\n\n15% Christmas bonus discount will be applied to all bookings made before 5 January 2019! \nWhy attend?\n\nThe new EU Medical Device Regulation (MDR) is in its implementation phase and will be effective from May 2020.  All medical devices will need to comply with this new legislation.  Similarly\, the IVD Regulation (IVDR) will be in force from May 2022.  Many companies are not yet ready for the journey let alone have a roadmap of how to get to compliance. Join this interactive workshop to find out more about the key areas of change within the MDR and IVD regulations.\n\nThis one-day event will:-\n• Provide you with an overview of the key areas likely to need upgrading to comply with the MDR/IVDR\n• Assist you in assessing your company’s current preparedness for the transition\n• Give you a clear\, practical guide to the next steps that you and your company need to take to gain CE Marking under the MDR/IVDR\n\nOutcomes\n• Gain an overview of the new EU Medical Device and IVD Regulations\n• Understand the key areas of compliance required\n• Understand the technical documentation that should be in place for each device\n• Gain a plan of action for implementation and CE Marking under the new legislation\n\nClick here to view the event agenda\n\nTarget Companies:  \nMedical Device & IVD companies as well as those Pharma companies with combination products\n\nTarget Market: \nC-suite\, executives\, product owners\, medical officers\, regulatory and clinical specialists within a company that need to understand the overall requirements of the new Medical Device Regulation and IVD Regulation for their medical devices to enable them to place a device on the market and to maintain access after May 2020. All company sizes will find it useful\, but particularly helpful for smaller\, resource constrained organisations.
URL:https://mediwales.com/event/the-new-eu-medical-device-ivd-regulations-implementation-insights-workshop/
LOCATION:Medilink West Midlands\, 4 Greenfield Crescent\, Edgbaston\, Birmingham \, B15 3BE
CATEGORIES:External
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190207T173000
DTEND;TZID=Europe/London:20190207T210000
DTSTAMP:20260406T184456
CREATED:20181217T162533Z
LAST-MODIFIED:20181217T162533Z
UID:15137-1549560600-1549573200@mediwales.com
SUMMARY:Medilink West Midlands: Medical and Healthcare Business Awards 2018
DESCRIPTION:Medilink West Midlands invites you to join us for a evening of celebration and entertainment at the 2018 Medical & Healthcare Business Awards on Thursday 7 February 2019. \nINTRODUCING OUR 2018 HEADLINE SPONSOR: MASTERCONTROL INC\nHosted at the Birmingham Conference and Events Centre\, a fabulous venue in central Birmingham\, the evening will consist of plenty of networking opportunities and surprises along the way! Make sure you grab yourself a glass of wine and enjoy the festivities\, before sitting down to a deliciously prepared 3 course meal. \nThe Awards Ceremony will begin after the meal\, where you will get the opportunity to meet each of the Awards Sponsors as they present the prestigious awards to each of our winners for the evening. \nDress code: Business Wear \nClick here to view the agenda for the night. \nTicket prices:  \nMedilink Members @ £40 +VAT \nNon Medilink Members @ £50 +VAT \nTable of 8 @ £300 +VAT \n2018 MedilinkWM Medical and Healthcare Business Awards – The categories are: \n-Start Up Award (sponsored by Calthorpe Estates) \n-Innovation Award (sponsored by Marks & Clerk) \n-Partnership with the NHS Award (sponsored by WMAHSN) \n-Supply Chain Award \n-Outstanding Achievement Award (sponsored by Medilink Midlands) \nClick here to download an application form. \nKeep an eye out for our Black Friday Sale\, for huge discounts on bookings!  \nFor more information\, please contact Vanessa Bailey\, Events Coordinator: VanessaB@medilinkWM.co.uk
URL:https://mediwales.com/event/medilink-west-midlands-medical-and-healthcare-business-awards-2018/
LOCATION:Birmingham Conference & Events Centre\, Hill Street \, Birmingham\, B5 4EW\, United Kingdom
CATEGORIES:External
ORGANIZER;CN="Medilink West Midlands":MAILTO:Lucy@MedilinkWM.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190207T173000
DTEND;TZID=Europe/London:20190207T210000
DTSTAMP:20260406T184456
CREATED:20190103T135027Z
LAST-MODIFIED:20190103T135027Z
UID:15154-1549560600-1549573200@mediwales.com
SUMMARY:Medilink West Midlands: Medical & Healthcare Business Awards 2018
DESCRIPTION:Medilink West Midlands invites you to join us for a evening of celebration and entertainment at the 2018 Medical & Healthcare Business Awards on Thursday 7 February 2019. \nIntroducing Our Headline Sponsor for 2018 MasterControl Inc \nHosted at the Birmingham Conference and Events Centre\, a fabulous venue in central Birmingham\, the evening will consist of plenty of networking opportunities and surprises along the way! Make sure you grab yourself a glass of wine and enjoy the festivities\, before sitting down to a deliciously prepared 3 course meal. \nThe Awards Ceremony will begin after the meal\, where you will get the opportunity to meet each of the Awards Sponsors as they present the prestigious awards to each of our winners for the evening. \nDress code: Business Wear \nClick here to view the programme for the night. \nTicket Costs: \nMember tickets: £40 + VAT \nNon Member tickets: £50 + VAT \nOnly £300 for a table of 8* \n*Limited tables available. Invoices will be forwarded after registration \n2018 MedilinkWM Medical and Healthcare Business Awards – The categories are: \nStart Up Award (sponsored by Calthorpe Estates) \nInnovation Award (sponsored by Marks & Clerk) \nPartnership with the NHS Award (sponsored by WMAHSN) \nSupply Chain Award \nOutstanding Achievement Award (sponsored by Medilink Midlands) \nClick here to download an application form. \nFor more information\, please contact Vanessa Bailey\, Events Coordinator: VanessaB@medilinkWM.co.uk \n\n\nBOOK NOW
URL:https://mediwales.com/event/medilink-west-midlands-medical-healthcare-business-awards-2018/
LOCATION:Birmingham Conference & Events Centre\, Hill Street \, Birmingham\, B5 4EW\, United Kingdom
CATEGORIES:External
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190208T100000
DTEND;TZID=Europe/London:20190208T160000
DTSTAMP:20260406T184456
CREATED:20190110T094642Z
LAST-MODIFIED:20190110T094642Z
UID:15178-1549620000-1549641600@mediwales.com
SUMMARY:CALIN Uncovered: Designing R&D solutions for local business
DESCRIPTION:We invite you to a showcase of Welsh companies\, being held at M-Sparc\, the new purpose built science park on Anglesey\, that have joined CALIN and already benefited from our support. \nDuring this informal event\, CALIN supported companies will share their experience of working with us and the benefits it brought to their businesses. The day will also provide the opportunity for you to talk to CALIN project staff\, network with companies like yours and begin to build your collaboration with CALIN. \nThe event will cover key topic areas: \n\nCreating partnerships – establishing collaboration with local businesses.\nDelivering R&D – benefits of collaborative working.\nAdvancing products to market – sustaining links to R&D to support introducing products to market.\n\nSpeakers confirmed: Camstech\, Diagnostig\, Phytorigins\, BioViciand BioCheckwith more to be announced soon.
URL:https://mediwales.com/event/calin-uncovered-designing-rd-solutions-for-local-business/
LOCATION:Menai Science Park Gaerwen\, LL60 6AG
CATEGORIES:External
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190213T150000
DTEND;TZID=Europe/London:20190213T170000
DTSTAMP:20260406T184456
CREATED:20190129T102602Z
LAST-MODIFIED:20190129T102602Z
UID:15216-1550070000-1550077200@mediwales.com
SUMMARY:California: Scale up your Biotech\, Medtech and Digital Health business in Irvine\, Orange County
DESCRIPTION:To help British companies explore business opportunities in Southern California \nLondon & Partners are organising a panel discussion with the city of Irvine/Orange County\, involving a senior delegation of business\, life science\, technology and funding experts\, in collaboration with OneNucleus\, the Association of British Healthtech Industries (ABHI)\, TechUK\, the UK Department of International Trade (and more partners). \nThe goal of this third mission to the U.K. is to build awareness for Irvine/Orange County and its life science/technology industry strength and identify\, connect with and encourage U.K.-based life science companies to look at Irvine/Orange County when they consider setting up a subsidiary in the U.S. and California. \nWhy attend? \n\nUK and Irvine/Orange county Life Science ecosystems:\n\nThere is great potential for exchanging expertise between the U.K. and Orange County clusters in how the regional ecosystem can be facilitated in creating and growing world class life science technology companies in biotech\, medtech and digital health. \n\nRaise funds in California:\n\nInformation on how to access the biggest Angel and Venture capital network in the US to scale up your company. \n\nAccess to a world class talent pool and business support:\n\nThe depth of the Irvine cluster in this field means it represents an excellent pool of talents\, investors and partners for UK-based companies seeking to set-up operations in the US \nProgramme: \n14.30 – Arrival and Registration \n15.00 – Welcome remarks by The Honorable Don Wagner\, Mayor of Irvine \n15.10 – Introduction of Irvine\, Orange County and the Southern California ecosystem \n15.20 – Panel Discussion with industry experts: “Building the Life Science & Med Tech ecosystem to accelerate success” \n16.10 – Short break \n16.20 – Panel Discussion with industry experts: “Scale-up your business in California: support available from accelerators\, industry associations and government agencies” \n17.10 – Networking \nModerator: \nLinda Di Mario\, Executive Director of Irvine Greater Chamber of Commerce \nSpeakers from California will include: \nBryan Starr\, Greater Irvine Chamber\, President & CEO \nLeigh Volkland\, Edwards Lifesciences\, Senior Director\, Government Affairs \nDr. Sesha Neervannan\, Senior Vice President\, Pharmaceutical Development\, Allergan \nBill Carpou\, OCTANe “Building the SoCal of Tomorrow”\, CEO \nDr. Steven Small\, University of California Irvine Medical Center\, Medical Innovation Institute Chief Scientific Officer \nSpeakers from the UK will include: \nA representative from Mayor’s International Business Programme (speaker TBC) \nA representative from the Department for International Trade (speaker TBC) \nA representative from ABHI (speaker TBC) \nA representative from TechUK (speaker TBC) \nA British company in Life Science / Digital health with a presence in Irvine (speaker TBC) \nWant individual appointments with the Irvine/Orange County delegation? \nFour full days of meetings with U.K. companies are being planned on 11-14 February\, just select the “individual appointment” ticket option. \nAbout us: \nLife Sciences in California \nA major industry Home to Life sciences innovators including companies\, laboratories and academic research institutes – employing 281\,000 people in 2\,848 companies and generating $130b annual revenue. Easy access to capital with 60% of the $62b venture capital in life sciences nationwide going to California based companies – Irvine Chamber has a network of partners in Venture Capital\, Angel Networks and the banking community ready to work with you. \nLife Sciences in Irvine/Orange County \nCutting edge R&D – Irvine and Orange County became a hotbed for the life science industry initially in the 1950s. Today it has 1\,100 life science companies\, employing more than 43\,000 persons generating $35.3b annually. Irvine has one of the top 100 universities on the Shanghai Index: University of California in Irvine (UCI). \nMajor companies: Edward Lifesciences\, Medtronic Heart Valves\, Toshiba America Medical Systems Inc\, Baxter International Inc\, Allergan Inc\, Teva Pharmaceuticals Industries\, Avid Bioservices\, Inc. \nTechnology ecosystem – Irvine has innovative start-up ecosystem and launch pads (such as OCTANe\, which connects new medical innovators to angel investors) specialising in medical devices and biotechnologies with a cost of business 50% less than Silicon Valley. \nGreater Irvine Chamber of Commerce \nWe help businesses connect with people\, resources\, new markets\, customers and capital. We encourage and nurture startups. We advocate for business interests. We pave the way for business success. We help foreign-owned companies find a “home” in Irvine/Orange County\, California. \nIn collaboration with an impressive network of public and private companies and organizations are ready to offer qualified life science companies a resource-rich package of decision-making incentives and transition benefits.
URL:https://mediwales.com/event/california-scale-up-your-biotech-medtech-and-digital-health-business-in-irvine-orange-county/
LOCATION:London & Partners 2 More London Riverside London SE1 2RR
CATEGORIES:External,International Events
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190214T093000
DTEND;TZID=Europe/London:20190214T133000
DTSTAMP:20260406T184456
CREATED:20190205T122543Z
LAST-MODIFIED:20190205T122543Z
UID:15240-1550136600-1550151000@mediwales.com
SUMMARY:Special Interest Group on Infection Prevention
DESCRIPTION:If you’re interested in Infection Prevention\, then this Special Interest Group will be of interest to you. \nDrawing on leading speakers and researchers in Infection Prevention\, this event will cover important topics such as: \n– Understanding the role of disinfectants and how resistance mechanisms are developed\n– Technological advances in detection of contamination and disinfection\n– Testing and development of antimicrobials for resistance in MRSA\n– Comparing persistent and non-persistent infections and their treatment \nThe event will be highly interactive and opportunity will be given to engage with both speakers and other delegates. \nOpportunities available to present for 5 minutes to showcase your products/services that are relevant to this event – click here to email your interest. \nThis free to attend event is being held by Medilink EM and the East Midlands Academic Health Science Network\, under our joint project LARIS (Lincolnshire & Rutland Innovation Support). The project aims to provide Innovation Support for Medical and Life Science businesses based in Lincolnshire & Rutland – to find out more\, click here. \nProgramme
URL:https://mediwales.com/event/special-interest-group-on-infection-prevention/
LOCATION:Belton Woods Hotel\, Belton  Grantham\, NG32 2LN United Kingdom
CATEGORIES:External
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190221T080000
DTEND;TZID=Europe/London:20190221T100000
DTSTAMP:20260406T184456
CREATED:20190208T155030Z
LAST-MODIFIED:20190208T155030Z
UID:15270-1550736000-1550743200@mediwales.com
SUMMARY:Brexit Briefing
DESCRIPTION:This breakfast event in partnership with Maetrics Ltd and Shakespeare Martineau LLP will provide an invaluable opportunity to find out the key legal and regulatory issues impacted by Brexit. \n  \nProgramme \n  \nThis event is free to attend\, spaces are limited and priority will be given to members of Medilink
URL:https://mediwales.com/event/brexit-briefing/
LOCATION:Discovery Building\, BioCity Nottingham\, NG1 1GF 
CATEGORIES:External
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190227T120000
DTEND;TZID=Europe/London:20190227T180000
DTSTAMP:20260406T184456
CREATED:20190205T145559Z
LAST-MODIFIED:20190205T150139Z
UID:15246-1551268800-1551290400@mediwales.com
SUMMARY:Bio Wales Showcase
DESCRIPTION:For a small country\, Wales has a lot to offer. \nFrom company success stories\, to strong links between industry and academia; a thriving Research and Development community; compelling inward investment proposition and a Life Sciences Hub to drive effective solutions for health and care services in Wales\, we have established firm foundations\, although want to go further! \nWales Week in London provides the perfect opportunity to share Wales with you and forge new relationships to accelerate innovation and economic benefit.Welsh Government want to start that conversation at our showcase event\, and networking lunch and drinks reception. \nSpeaker Programme:\nProfessor Keith Harding – Medical Director\, Welsh Wound Innovation Centre\nMark Briggs – Head of Cell and Gene Strategy\, Welsh Blood Service\nProfessor Krish Singh – Head of Human Electrophysiology\, CUBRIC\nPhillip Webb – Planning and Performance\, Velindre NHS Trust\nGareth Healey – Project Manager\, CALIN\nProfessor Steve Conlan – Head of Innovation\, Swansea School of Medicine\nMike Moran – CEO\, Proton Partners\nSimon Tyler – COO\, CatSci \nEmail LifeSciences@gov.wales to register your interest \nFor more information please visit: https://walesweek.london/whats-on/innovate-engage-inspire-this-is-life-sciences-this-is-wales
URL:https://mediwales.com/event/bio-wales-showcase/
LOCATION:Rocket Space\, London
CATEGORIES:External
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190228T090000
DTEND;TZID=Europe/London:20190228T133000
DTSTAMP:20260406T184456
CREATED:20190211T110901Z
LAST-MODIFIED:20190211T110901Z
UID:15274-1551344400-1551360600@mediwales.com
SUMMARY:Sensing and Imaging for diagnostics\, detection and monitoring
DESCRIPTION:This event will share a wide range of developments in sensing and imaging technologies which can be used in new medical devices to improve diagnostics\, detection and monitoring of clinical signs. \nPresentation topics include: \n– Sensing inside the cell with miniaturised analytical devices\n– Sensing and imaging at micro and nano-scales using non-invasive biophotonic techniques: for diagnosis\, toxicity assessment and other clinical uses\n– Optical and physiological monitoring – from textiles to critical care to surgical instrumentation\n– From sensing data to advanced diagnostic and therapeutic tools focussing on data analysis\n– Utilising 3D tracking technology and systems for healthcare diagnostics\, detection and monitoring \nPlus the whole process of developing medical devices from bench to bedside will be discussed combining industry\, academia and NHS input with the opportunity to explore new collaborations \nThis free to attend event is being held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. \nProgramme \nBook Now
URL:https://mediwales.com/event/sensing-and-imaging-for-diagnostics-detection-and-monitoring/
LOCATION:NOTTS COUNTY FOOTBALL CLUB\, MEADOW LANE STADIUM\, MEADOW LANE\, NOTTINGHAM\,  NG2 3HJ\, United Kingdom
CATEGORIES:External
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190228T090000
DTEND;TZID=Europe/London:20190301T150000
DTSTAMP:20260406T184456
CREATED:20190205T154717Z
LAST-MODIFIED:20190205T154717Z
UID:15249-1551344400-1551452400@mediwales.com
SUMMARY:4TH Annual MarketsAndMarkets Infection Control\, Sterilisation & Decontamination In Healthcare Congress
DESCRIPTION:4th Annual MarketsandMarkets Infection Control\, Sterilization & Decontamination in Healthcare Congress will address issues associated with decontaminating process efficacy and infection free hospital environment. \nThe congress will take place on 28 February – 1 March 2019 in London – UK. \nYou can view the post show report for the 3rd Annual Infection Control\, Sterilization & Decontamination here \nAs quoted by House of Commons Library on 14 May 2018 “UK healthcare-associated infections cost lives and money. Some 300\,000 healthcare-associated infections every year cost the NHS in excess of £1 billion annually” \nThe increasing use of antibiotics in medicine prescription around the world is constantly causing bacteria to mutate and become resistant to drugs. Also\, every surgical instrument has their own set of procedures for cleaning\, as stated by their manufacturer. \nThere are lot of efforts taken by NHS to reuse device related Healthcare Associated Infections through their standardized training and effective decontaminating process\, but the main issues are- are we really implementing our process and reaching efficacy in decontamination and making the hospital environment infection free. \n\nKEY HIGHLIGHTS\n\nDetailed coverage on Sepsis | Constructive talk on Antimicrobial Resistance | Effective management of Upper Respiratory Infections and CJD | Dealing and preventing Healthcare Associated Infections | Misfolded protein related diseases as from the perspective of decontamination and infection control | Reprocessing of flexible endoscope and difficult surgical instruments | Comparative case study on UVC Room decontamination – using Fumigation technologies or UV based room treatment systems | Clean water system for effective decontamination \n\nWHO SHOULD ATTEND\n\nInfection Control:  \nDirectors | Heads | Doctors | Nurses | Specialists | Consultants \nDecontamination: \nClinical lead | Consultants | Manager | Deputy Manager | Site Manager | Director | MD | Service Manager | General Manager | Technical advisor | Heads | Central Decontamination | Trainers \nSterilization: \nCSSD (Central sterile service department) | Head of Sterile services | Consultants | Manager | Deputy Manager \nEndoscopy Managers \nQuality Improvement Managers \nFrom Hospitals\, Home Care\, Research Institutes and Universities \n  \nHead over to the website to choose your plan: http://events.marketsandmarkets.com/4th-Annual-Infection-Control-Sterilization-Decontamination-in-Healthcare-Congress/
URL:https://mediwales.com/event/4th-annual-marketsandmarkets-infection-control-sterilisation-decontamination-in-healthcare-congress/
LOCATION:Hotel Novotel London West\, Hammersmith International Ctre 1\, Shortlands\, London\, W6 8DR
CATEGORIES:External
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190228T090000
DTEND;TZID=Europe/London:20190301T150000
DTSTAMP:20260406T184456
CREATED:20190205T160135Z
LAST-MODIFIED:20190205T160252Z
UID:15253-1551344400-1551452400@mediwales.com
SUMMARY:2ND Annual MarketsandMarkets Infectious Diseases Diagnostic Conference
DESCRIPTION:After the success of inaugural congress held on 21st -22nd February 2018\, MarketsandMarkets is organising 2nd annual MarketsandMarkets Infectious Diseases Diagnostic Conference to be held on 28th February – 1st March 2019 in Central London\, UK \nAccording to the World Health Organization\, 17 million deaths are caused each year by infectious diseases\, accounting for nearly 30% of the annual mortality rate worldwide. \nLower respiratory tract infections\, HIV/AIDS\, gastro-intestinal diseases\, malaria and tuberculosis are together responsible for nearly one-third of all deaths. Various technological developments and advancements in vitro diagnostics have led to a new variety of diagnostic tests\, allowing patients to access novel treatments earlier. \nThis conference aims to bring different stakeholders together from hospitals\, laboratories\, academic institutes and IVD industry leaders to discuss about the emerging technologies and potential growth of molecular diagnostics and challenges faced in point-of-care testing and antimicrobial resistance. Keynote presentations\, Brainstorming Panel Discussions and Case studies will give the stakeholders an opportunity to discuss and understand the issues faced. \n\nKEY HIGHLIGHTS\n\nDiscussion on the treatment and diagnosis of fungal infection\, flu\, Hepatitis C | Antibiotic Resistance: Consequences of overtreating infectious disease | Talks on Neglected Tropical Diseases (NTDs) diagnostic | Rapid TB/Ref R testing | The clinical need for better antimicrobial resistance related diagnostics | Treatments of MDR gram negative bacteria | Time required to diagnosis vancomycin-resistant enterococci (VRE) \n\nWHO SHOULD ATTEND\n\nFrom Hospitals\, Reference Laboratories\, Research Institutes and Academics \nDirectors\, head of laboratory\, Lab Managers\, Deputy Lab Managers\, Chief/Head Biomedical Scientist\, Laboratory Technician\, Professors\, Associate Professors\, Research Fellow\, POCT lead\, Consultant Microbiologist\, Nurses\, Professors\, Clinical Services. \nDepartments: \nPathology | Molecular pathology | Biochemistry/ Clinical biochemistry | Microbiology/ Clinical Microbiology | Molecular Biology | Virology | Infectious diseases | Point of care testing | Infection Control \nWhy attend? \nFind out new developments and emerging methods of diagnostics for infectious disease | Contribute to interactive roundtables with your peers to deliberate key topics most relevant to you | Explore the latest platforms and technologies on the market for development | Discuss the best tool for your research in pathology | Share your work and achievements with your industry peers in the Poster Session \n  \nTo choose your plan head over to the event website: http://events.marketsandmarkets.com/2nd-annual-infectious-diseases-diagnostics-conference/ \n 
URL:https://mediwales.com/event/2nd-annual-marketsandmarkets-infectious-diseases-diagnostic-conference/
LOCATION:Hotel Novotel London West\, Hammersmith International Ctre 1\, Shortlands\, London\, W6 8DR
CATEGORIES:External
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190306T123000
DTEND;TZID=Europe/London:20190306T164500
DTSTAMP:20260406T184456
CREATED:20190128T163207Z
LAST-MODIFIED:20190128T163207Z
UID:15213-1551875400-1551890700@mediwales.com
SUMMARY:mHealth App National Workshop
DESCRIPTION:SEHTA and ORCHA are holding this workshop on mHealth Apps to help innovators working on app development for mHealth Apps to understand the technical requirements and evaluation for your innovation. \nDate: Wednesday 6th March \nVenue: Hempsons\, 100 Wood Street\, London\, EC2V 7AN \nTimes: 12:30 – 16:45 \nCost to attend:  SEHTA Members £149 + VAT / Non-members £199 + VAT \nThis workshop will also be run by Medilink East & West Midlands & Medilink North of England during 2019. Check out their websites for further details.  \nVenue kindly supported by  \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \nThe NHS and national health bodies across the world are revolutionising services through the integration of digital health solutions\, leading to more patient-centred and efficient care.  Frameworks guide the identification of health apps that will safely make the biggest impact in terms of improving outcomes. \nAs a developer\, it can be hard to know what technical requirements and evaluation will be imperative\, and how to navigate the system to ensure the right people know about your innovation. \nThis workshop aims to give developers clear guidance\, helping to get to the right market with the right product\, fit for NHS and worldwide quality standards. \nCome and be part of the day\, to learn: \n\nWhat the app accreditation landscape is across the UK\, EU and globally\nWhat interoperability and data sharing with clinical data sets is and what it means for you?\nHow to get traction in the NHS and the public sector\nHow to build a ROI case for your product\n\nThe day will consist of quick pace presentations followed by panel discussions. Be ready with your questions! \n \nPlease note that places are limited & the organisers have the right to review all applications.  Confirmation will be sent by 22nd Feb and invoices will be sent separately by SEHTA. \nPlease note that in compliance with our GPDR policy\, by registering for this event\, you are automatically added to our mailing list.  If you wish to unsubscribe email info@sehta.co.uk with your details. \n\n\n\n\n\nTime\nProgramme\n\n\n12.30 – 13:30\nRegistration & Networking Lunch\n\n\n13:30 – 13:40\nWelcome and introduction to the mHealth market place: MedTech and Apps \nLiz Ashall-Payne\, CEO\, ORCHA & Dr David Parry\, CEO\, SEHTA\n\n\n13:40 – 14:10\nNational perspective mHealth \nSpeakers TBC\n\n\n14:10 – 14:30\nmHealth App interoperability \nWhat are the foundations for achieving data integration and an interoperable Ecosystem? \n\nWhat is interoperability?\nWhy is it important?\nEU Voluntary Code of Conduct on mHealth Apps\nMarket Perspectives\nThe Digital Health Society\n\nBleddyn Rees\, Digital Health Consultant\, Obsourne Clarke\n\n\n\n\n\n\n14:30 – 15:00\nmHealth Regulation and Technical Safety \nWhat are the current regulations and what new requirements are coming shortly for mHealth? \nTim Andrews\, COO\, ORCHA & Speaker TBC\n\n\n15:00 – 15:30\nRefreshment Break\n\n\n15:30 – 16:00\nApps in Clinical Practice \nHow and where are Apps being used in clinical practice today? And what are the barriers and opportunities to making mHealth part of what is done in everyday clinical practice? \nDr Chris Mimnagh\, GP\, Clinical Safety Officer\n\n\n16:00 – 16:30\nSustainable commercial models for mHealth \nWhat is required to achieve a sustainable business model which drives value and revenue in mHealth? \nSimon Leigh\, Health Economist\, ORCHA\n\n\n16:30 – 16:45\nFinal comments and next steps \nLiz Ashall-Payne & Dr David Parry\n\n\n16:45\nClose
URL:https://mediwales.com/event/mhealth-app-national-workshop/
LOCATION:Hempsons\, 100 Wood Street\, London\, EC2V 7AN\, United Kingdom
CATEGORIES:External
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190307T090000
DTEND;TZID=Europe/London:20190307T130000
DTSTAMP:20260406T184456
CREATED:20190211T111128Z
LAST-MODIFIED:20190211T111128Z
UID:15275-1551949200-1551963600@mediwales.com
SUMMARY:Food Supplements Special Interest Group (SIG)
DESCRIPTION:Probiotics and the Gut Microbiome. \nAs part of a two part special interest group initiative\, Farm to Fork\, with our sister SIG\, Infectious Disease (co-ordinated by Dr Katie Laird\, DMU) we are looking at the nutrition perspective of microbiology\, namely probiotics and why a healthy gut is important. Micro-organisms are integral to our health and wellbeing. In these two networking meetings we shall be exploring how the role of micro-organisms both good and bad are pivotal to our continued health. \n7 March – This event will look at the impact of the microbiome\, influence of probiotics (what they are and how they are regulated) and how to innovate in this area. \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. \nPlease note: Individual registration is required for each event. By clicking BOOK NOW you will be registered for 7 March only.  \n3 April – The Infectious Disease SIG will explore the links between food production and antibiotic resistance in the environment and the impact this can have on health. Click here for further details. \nProgramme  \nBook Now
URL:https://mediwales.com/event/food-supplements-special-interest-group-sig/
LOCATION:Discovery Building\, BioCity Nottingham\, NG1 1GF 
CATEGORIES:External
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190307T093000
DTEND;TZID=Europe/London:20190307T160000
DTSTAMP:20260406T184456
CREATED:20190103T135258Z
LAST-MODIFIED:20190103T135258Z
UID:15155-1551951000-1551974400@mediwales.com
SUMMARY:Concept Development and Quality Management Systems
DESCRIPTION:Medilink Members fee: £180 + VAT \nNon Medilink Members fee: £215 + VAT \n15% Christmas bonus discount will be applied to all bookings made before 5 January 2019! \nThis one-day event will:- \n-Provide you with an overview of the requirements for the concept design phase of a medical device \n-Assist you in assessing your company’s current readiness for implementing a QMS \n-Give you a clear\, practical guide to the next steps that you and your company need to take to move \nthrough to the next design phase \nOutcomes \n-Understand the key areas of concept development required \n-Gain an overview of the regulatory and quality management system requirements for a concept \nmedical device \n-Understand the technical documentation that should be in place for this stage of device \ndevelopment \n-Explore early stage risk management and next steps planning \n\n\nBOOK NOW
URL:https://mediwales.com/event/concept-development-and-quality-management-systems/
LOCATION:Medilink West Midlands\, 4 Greenfield Crescent\, Edgbaston\, Birmingham \, B15 3BE
CATEGORIES:External
ORGANIZER;CN="Medilink West Midlands":MAILTO:Lucy@MedilinkWM.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20190307T100000
DTEND;TZID=Europe/London:20190307T150000
DTSTAMP:20260406T184456
CREATED:20190219T142833Z
LAST-MODIFIED:20190219T142833Z
UID:15301-1551952800-1551970800@mediwales.com
SUMMARY:Women in Leadership\, Innovation and Entrepreneurship
DESCRIPTION:International Women’s Day is a global day celebrating the social\, economic\, cultural and political achievements of women. The day also marks a call to action for accelerating gender parity and the race is on to build a more gender-balanced world – #BalanceforBetter \nIn celebration of International Women’s Day\, this event will focus on the theme of Women in Leadership\, Innovation and Entrepreneurship; it will showcase some of the extraordinary successes women in Wales have had over recent years\, along with exploring the breakthrough’s being made in terms of gender equality\, and some of the main challenges that still exist today that we can work together to address.  The event is open to all\, free to attend\, and includes the following line-up: \n\n10.30 – 10.45   Welcome and Introduction to Athena Swan at Swansea University; Professor Hilary Lappin-Scott OBE\, Senior Pro-Vice Chancellor\n10.45 – 11.00   Laura Baker\, Head of Product Management & New Product De-velopment\, Tata Steel UK\n11.00 – 11.15   Sarah John\, Founder\, Boss Brewery Co\n11.15 – 11.25   Dr Geertje Van Keulen\, Best Women in STEM Award Winner\n11.25 – 11.35   Professor Catherine Thornton\, Deputy Head of Swansea University Medical School\n11.35 – 11.50   Victoria Bates\, Healthcare Operations Director\, Pfizer\n11.50 – 12.05   Cari-Anne Quinn\, CEO\, Life Science Hub\n12.05 – 12.15   Professor Shareen Doak\, Swansea University Medical School\n12.15 – 12.35   Speaker Q&A\n12.35 – 13.25   Lunch and Networking\n13.25 – 13.45   Julie James AM\, Welsh Government\n13.45 – 14.00   Fiona Spowers\, Director\, Riversimple\n14.00 – 14.30   In Conversation with14.30 – 14.40   Professor Gwyneth Davies\, Swansea University Medical School\n\nHannah Lamden\, Finery Media\nCanisha Chakadya – Phoenix Subscriptions\n\n\n14.40 – 14.55   Rayner Davies\, A&R Cleaning Services\n14.55 – 15.00   Closing Remarks; Professor Hilary Lappin-Scott OBE\, Senior Pro-Vice Chancellor\n15.00   Finish & Networking\n\nDelivered in collaboration with Swansea University: LINC\, The Morgan Academy\, Athena SWAN\, ION Leadership\, CALIN\, BEACON and colleagues across Swansea University.
URL:https://mediwales.com/event/women-in-leadership-innovation-and-entrepreneurship/
LOCATION:Unnamed Venue\, Swansea
CATEGORIES:External
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190311
DTEND;VALUE=DATE:20190318
DTSTAMP:20260406T184456
CREATED:20190103T143514Z
LAST-MODIFIED:20190103T143514Z
UID:15156-1552262400-1552867199@mediwales.com
SUMMARY:Trade Mission to Japan and South Korea
DESCRIPTION:Join the DIT Trade Mission to South Korea and Japan to gain insight into opportunities in these 2 markets\, expand your business potential and cultivate a network of contacts within the Korean and Japanese Medtec industries. \nThe Department for International Trade are coordinating a trade mission to Tokyo and Seoul.  During this activity companies can take part in the following activity: \n\nExhibit at KIMES 2019: Use of a shared meeting and exhibition space on DIT stand.  This shared 36sqm space offers companies communal meeting space\, UK branding and individual company marketing displays.\nMarket Briefing S.Korea: Briefing and information session at British Embassy in Seoul.\nNetworking Reception S.Korea: Distributors\, agents\, academics\, clinicians and key government affiliates will be invited to this British reception.\nSeminar Japan: Participants will have the opportunity to present for 15 minutes at the British Embassy in Tokyo to a selected audience of over 50 Japanese representatives.  Simultaneous translation will be provided along with the translation of company profiles.\nMarket Briefing Japan: Briefing and information session at British Embassy in Tokyo.  This will be followed by a visit and tour around a local hospital.\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nParticipation Costs \nThis trade mission is split into two parts\, giving companies the flexibility to visit just one market or both markets and engage with the activity most valuable to their organisation. \nSouth Korea£2\,500 – This cost includes all in market activity\, use of the shared exhibition stand space and accommodation close to the KIMES exhibition.  TAP grants of £2\,500 are available to eligible companies. \nJapan£770 – This cost includes all activity in Tokyo and support from DIT in market team.  Additional activity and an extension of the programme can be discussed individually if required. \n*All travel arrangements must be made and paid for by the delegate (advice and support will be offered)**TAP grants are available on a first come first served basis to eligible UK based companies***All prices are exclusive of VAT \n\n\n\n\n\n\n\n\n\n\n\n\n\nHow to Join \nPlease register your interest by completing the online application form:https://exporttojapan.co.uk/events/medtech-mission-to-kimes-south-korea-and-japan/ \nThe deadline for expressing interest in this trade mission is Friday 18th January 2019. \nFor more information\, please contact:DIT Korea – Eunjung.lee@fco.gov.ukDIT Japan – lifesciencetradejapan@mobile.trade.gov.ukMedilink – t.elliott@medilink.co.uk  \n\n\n\n\n\n\n\n\n\n\n\n\n\nWhy Go to Japan and South Korea?  \nSouth KoreaThe South Korean medical devices market is the 9th largest in the world\, valued at valued at £4.4 billion. The market is continuously growing with CAGR of 6.3%. The healthcare system in the country is known to be high quality and efficient\, with the Korean National Health Insurance System (KNIS) providing near universal healthcare coverage to the population of 51 million. Relatively high consumption of alcohol and tobacco\, plus increasingly sedentary lifestyles and an ageing population means Korea faces a growing burden of non-communicable disease and is reliant on new technologies to keep up with the population’s needs. \nKorea has a lot of opportunities for UK companies\, particularly for products using cutting edge technology in digital health\, orthopaedics\, wound care\, dental\, ophthalmic products and elderly care. Local firms and hospitals have expressed interest in products such as dental implants\, ultrasound imaging systems\, grafts/prostheses\, biomaterials\, and PACS. There is a strong appetite for UK products\, with the UK ranking as 7th in the list of biggest importers to Korea in 2016. \nJapanJapan’s medical devices and healthcare market offers business opportunities for innovative British companies. It is the second largest medical devices market after the US with a large number of hospitals. It offers universal access and national healthcare services\, and the world’s highest life expectancies. Premium pricing is also available for healthcare innovations. Japan’s medical devices market\, valued at over £20 billion\, heavily relies on imports\, especially for therapeutic devices\, which consist of nearly 50% of the total domestic sales volume. The UK is ranked as the 8th largest exporter of medical devices to Japan. Also\, since the revision of the Pharmaceutical and Medical Devices Act in 2014\, regulations on medical devices have been modified to allow faster and easier access to the Japanese medical devices market. Japan’s approval process is now roughly equivalent to the US. \nJapan offers a great opportunity for UK companies involved in the development of innovative medical technology\, particularly in the following areas: artificial internal organ apparatus and assistive devices\, high tech operating equipment and supplies\, ophthalmic goods\, diagnostic imaging system; therapeutic and surgical equipment and home treatment equipment.
URL:https://mediwales.com/event/trade-mission-to-japan-and-south-korea/
LOCATION:Japan & South Korea
CATEGORIES:External
ORGANIZER;CN="DIT KOREA LIFE SCIENCES TEAM & DIT JAPAN LIFE SCIENCES TEAM":MAILTO:lifesciencetradejapan@mobile.trade.gov.uk
END:VEVENT
END:VCALENDAR